Rachel McMinn's Net Worth
$541 Thousand
Who is Rachel McMinn?
Rachel McMinn does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include INTERCEPT PHARMACEUTICALS INC, and Neurogene Inc..
SEC CIK
Rachel McMinn's CIK is 0001606302
Past Insider Trading and Trends
2014 was Rachel McMinn's most active year for acquiring shares with 3 total transactions. Rachel McMinn's most active month to acquire stocks was the month of January. 2016 was Rachel McMinn's most active year for disposing of shares, totalling 7 transactions. Rachel McMinn's most active month to dispose stocks was the month of June. 2024 saw Rachel McMinn paying a total of $0.00 for 93,282 shares, this is the most they've acquired in one year. In 2015 Rachel McMinn cashed out on 755 shares for a total of $181,642.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INTERCEPT PHARMACEUTICALS INC (ICPT) No price found
Chief Strategy OfficerRachel McMinn owns 16,875 units of Common Stock. In the year 2014 Rachel McMinn filed a total of 21 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.65% | -283.00 |
$58.89 | -$16,666.78 | 16.88K |
Oct 2
| |||
Form 4
| -0.75% | -130.00 |
$123.12 | -$16,005.29 | 17.16K |
Jul 31
| |||
Form 4
| -1.46% | -257.00 |
$121.78 | -$31,297.46 | 17.29K |
Jul 3
| |||
Form 4
| -0.65% | -114.00 |
$113.12 | -$12,895.69 | 17.55K |
May 1
| |||
Form 4
| -1.43% | -257.00 |
$115.00 | -$29,554.31 | 17.66K |
Apr 3
| |||
Form 4
| +38.71% | 5K |
—
|
—
| 17.92K |
Feb 1
| |||
Form 4
| -5.94% | -816.00 |
$103.92 | -$84,797.99 | 12.92K |
Jan 3
| |||
Form 4
| -0.93% | -129.00 |
$123.82 | -$15,972.33 | 13.73K |
Oct 31
| |||
Form 4
| -0.89% | -125.00 |
$176.57 | -$22,070.62 | 13.86K |
Aug 1
| |||
Form 4
| -0.75% | -106.00 |
$145.11 | -$15,381.58 | 13.99K |
Jul 5
| |||
Form 4
| -0.91% | -130.00 |
$147.49 | -$19,173.71 | 14.09K |
May 2
| |||
Form 4
| -0.73% | -104.00 |
$130.76 | -$13,599.04 | 14.22K |
Apr 4
| |||
Form 4
| +87.91% | 6.7K |
—
|
—
| 14.32K |
Feb 10
| |||
Form 4
| -1.65% | -128.00 |
$103.56 | -$13,255.80 | 7.62K |
Feb 1
| |||
Form 4
| -5.71% | -469.00 |
$145.90 | -$68,428.84 | 7.75K |
Jan 4
| |||
Form 4
| -1.50% | -125.00 |
$160.24 | -$20,029.40 | 8.22K |
Nov 2
| |||
Form 4
| +94.34% | 4.05K |
—
|
—
| 8.34K |
Oct 1
| |||
Form 4
| -2.87% | -127.00 |
$262.09 | -$33,285.77 | 4.29K |
Jul 31
| |||
Form 4
| -10.22% | -503.00 |
$255.12 | -$128,327.17 | 4.42K |
May 1
| |||
Form 4
|
∞
| 4.92K |
—
|
—
| 4.92K |
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neurogene Inc. (NLTX) No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||